Massive liver cancer gene study completed – could pave way for smarter treatments
NCT ID NCT03071458
First seen Jan 05, 2026 · Last updated Jun 19, 2026 · Updated 32 times
Summary
This completed study looked at the genetic makeup of liver cancer in 808 patients. Researchers analyzed tumor samples to identify key genetic changes and patterns. The goal was to better understand the disease and find ways to classify tumors more precisely, which could eventually lead to more personalized care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIRRHOSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
INSERM
Paris, 75010, France
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this research could help doctors better classify liver cancer and choose more personalized treatments in the future.
What could go wrong
This is an observational study, not a treatment trial. The findings may not directly lead to new therapies or benefit current patients.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.